Literature DB >> 16369208

Growth hormone / insulin-like growth factor-1 axis during puberty.

Athanasios Christoforidis1, Ilianna Maniadaki, Richard Stanhope.   

Abstract

Puberty is a dynamic, transitional period of life which is characterized by the acquisition of secondary sexual characteristics leading to the development of fertility. Puberty is accompanied by sexually dimorphic changes in linear growth, body proportions and body composition. The pubertal growth spurt is influenced by a number of factors such as hormones, nutrition, physical activity and general health, acting mostly in concert in order to modify a genetic potential for growth. Growth hormone (GH) is traditionally considered to be the main regulator of growth. During puberty, elevated sex steroid concentrations (especially oestrogens) stimulate GH production, leading to an activation of the whole GH/Insulinlike growth factor-1 (IGF-1) axis. This activation is mostly characterized by an increase in the amplitude of GH pulses rather than an increase in frequency or in duration. Interactions between GH and sex steroids (especially androgens) express an anabolic effect on muscle mass, bone mineralization and body proportion which constitutes the male and the female adult body composition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16369208

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  18 in total

Review 1.  Therapies for musculoskeletal disease: can we treat two birds with one stone?

Authors:  Christian M Girgis; Nancy Mokbel; Douglas J Digirolamo
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

2.  Long-term auxological and pubertal outcome of patients with hereditary insulin-like growth factor-I deficiency (Laron and growth hormone-gene deletion syndrome) treated with recombinant human insulin-like growth factor-I.

Authors:  M F Messina; T Arrigo; M Valenzise; L Ghizzoni; M Caruso-Nicoletti; S Zucchini; P Chiabotto; G Crisafulli; G Zirilli; F De Luca
Journal:  J Endocrinol Invest       Date:  2010-06-11       Impact factor: 4.256

Review 3.  Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle.

Authors:  Robert A Frost; Charles H Lang
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-10       Impact factor: 4.741

Review 4.  The role of GH/IGF-I-mediated mechanisms in sex differences in cortical bone size in mice.

Authors:  Lisa E Olson; Claes Ohlsson; Subburaman Mohan
Journal:  Calcif Tissue Int       Date:  2010-11-27       Impact factor: 4.333

5.  Cloning and characterization of class 1 and class 2 insulin-like growth factor-I mRNA in Songliao black pig.

Authors:  Shuqi Xiao; Shuang Li; Jiabao Zhang; Shumin Zhang; Lisheng Dai; Yonghua Bao; Ning Jiang; Yan Gao; Zhongli Zhao; Delin Mo; Yaosheng Chen; Zhihui Zhao
Journal:  Mol Biol Rep       Date:  2007-12-23       Impact factor: 2.316

6.  Negative regulation of human growth hormone gene expression by insulin is dependent on hypoxia-inducible factor binding in primary non-tumor pituitary cells.

Authors:  Hana Vakili; Yan Jin; Peter A Cattini
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

Review 7.  Skeletal effects of growth hormone and insulin-like growth factor-I therapy.

Authors:  Richard C Lindsey; Subburaman Mohan
Journal:  Mol Cell Endocrinol       Date:  2015-09-25       Impact factor: 4.102

8.  Increased SULT1E1 activity in HepG2 hepatocytes decreases growth hormone stimulation of STAT5b phosphorylation.

Authors:  Li Li; Dongning He; Teresa W Wilborn; Josie L Falany; Charles N Falany
Journal:  Steroids       Date:  2008-09-11       Impact factor: 2.668

9.  IGF and insulin receptor signaling in breast cancer.

Authors:  Antonino Belfiore; Francesco Frasca
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-19       Impact factor: 2.673

Review 10.  Role of IGF1 and EFN-EPH signaling in skeletal metabolism.

Authors:  Richard C Lindsey; Charles H Rundle; Subburaman Mohan
Journal:  J Mol Endocrinol       Date:  2018-03-26       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.